A company spokesperson told Fierce Medtech that Abbott estimates the issue will affect less than 1% of FreeStyle Libre 3 users in the U.S. (Abbott) Abbott is asking users of its FreeStyle Libre 3 ...

Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...

The US Food and Drug Administration (FDA) has tagged Abbott's recent recall of its faulty FreeStyle Libre 3 sensors as Class I, the most serious designation the agency can hand out for a recall. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Abbott issued a medical device correction for some ...

The FDA designated this a Class I Recall after 860 serious injuries and 7 deaths were reported related to falsely low glucose readings. Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and ...

Abbott Laboratories has initiated a voluntary recall of a small number of FreeStyle Libre 3 sensors within three lots distributed throughout the US. Designed to be what the company says is the world’s ...

Abbott Laboratories has issued an urgent medical device correction concerning its FreeStyle Libre 3 sensors. The announcement on the company’s official website highlights a defect in a specific batch ...

– Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now ...

Tandem’s Control-IQTM hybrid closed-loop technology now integrates with the 15-day continuous glucose monitoring sensor. This ad will auto-close in 10 seconds ...